Log in

TSE:WEEDCanopy Growth Stock Price, Forecast & News

C$23.66
+1.88 (+8.63 %)
(As of 07/10/2020 04:00 PM ET)
Add
Compare
Today's Range
C$21.68
Now: C$23.66
C$23.72
50-Day Range
C$21.63
MA: C$23.56
C$30.57
52-Week Range
C$12.96
Now: C$23.66
C$47.94
Volume1.54 million shs
Average Volume2.54 million shs
Market CapitalizationC$8.73 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada to investigate the efficacy of cannabinoids for the treatment of post-concussion neurological diseases in former NHL players; and partnership with Parent Action on Drugs. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
Read More
Canopy Growth logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.2Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.28 out of 5 stars


Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryCannabis
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-613-5999600

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$398.77 million
Cash FlowC$5.36 per share
Book ValueC$13.96 per share

Profitability

Miscellaneous

Employees2,700
Market CapC$8.73 billion
Next Earnings Date8/10/2020 (Estimated)
OptionableNot Optionable

Receive WEED News and Ratings via Email

Sign-up to receive the latest news and ratings for WEED and its competitors with MarketBeat's FREE daily newsletter.

Canopy Growth (TSE:WEED) Frequently Asked Questions

How has Canopy Growth's stock been impacted by COVID-19 (Coronavirus)?

Canopy Growth's stock was trading at C$18.33 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, WEED shares have increased by 29.1% and is now trading at C$23.66. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Canopy Growth?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Canopy Growth in the last year. There are currently 1 sell rating, 3 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Canopy Growth.

When is Canopy Growth's next earnings date?

Canopy Growth is scheduled to release its next quarterly earnings announcement on Monday, August 10th 2020. View our earnings forecast for Canopy Growth.

What price target have analysts set for WEED?

8 Wall Street analysts have issued 12 month price objectives for Canopy Growth's shares. Their forecasts range from C$20.00 to C$60.00. On average, they anticipate Canopy Growth's share price to reach C$34.50 in the next year. This suggests a possible upside of 45.8% from the stock's current price. View analysts' price targets for Canopy Growth.

Has Canopy Growth been receiving favorable news coverage?

News stories about WEED stock have trended neutral this week, InfoTrie reports. InfoTrie identifies negative and positive news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Canopy Growth earned a news sentiment score of 0.4 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term. View the latest news about Canopy Growth.

Who are some of Canopy Growth's key competitors?

What other stocks do shareholders of Canopy Growth own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Canopy Growth investors own include Canopy Growth (CGC), Aurora Cannabis (ACB), Aphria (APHA), Aurora Cannabis (ACB), Auxly Cannabis Group (CBWTF), KushCo (KSHB), Cronos Group (CRON), Aurora Cannabis (ACBFF), GW Pharmaceuticals PLC- (GWPH) and Alibaba Group (BABA).

Who are Canopy Growth's key executives?

Canopy Growth's management team includes the following people:
  • Mr. Bruce A. Linton, Co-Founder, Chairman & Co-CEO (Age 52)
  • Mr. Mark Anthony Nicholas Zekulin, Pres & Co-CEO
  • Mr. Timothy Rob Saunders, Exec. Officer
  • Mr. Rade Kovacevic, Exec. VP
  • Mr. Mike Lee, Acting Chief Financial Officer

What is Canopy Growth's stock symbol?

Canopy Growth trades on the Toronto Stock Exchange (TSX) under the ticker symbol "WEED."

How do I buy shares of Canopy Growth?

Shares of WEED and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Canopy Growth's stock price today?

One share of WEED stock can currently be purchased for approximately C$23.66.

How big of a company is Canopy Growth?

Canopy Growth has a market capitalization of C$8.73 billion and generates C$398.77 million in revenue each year. Canopy Growth employs 2,700 workers across the globe.

What is Canopy Growth's official website?

The official website for Canopy Growth is www.canopygrowth.com.

How can I contact Canopy Growth?

Canopy Growth's mailing address is 1 Hershey Dr, SMITHS FALLS, ON K7A 0A8, Canada. The company can be reached via phone at +1-613-5999600.

This page was last updated on 7/12/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.